Literature DB >> 26987292

Precise and efficient siRNA design: a key point in competent gene silencing.

E Fakhr1,2, F Zare1,2, L Teimoori-Toolabi2.   

Abstract

RNA interference-related strategies have become appealing methods in various fields of research. Exact sequence design of these small molecules is an essential step in the silencing procedure. Numerous researchers have tried to define some algorithms in order to increase the chance of short interfering RNA's (siRNA's) success. In recent decades, online designing software has aimed at promoting the quality of siRNA designing based on the most cited algorithms. According to our previous experiments, a combination of different criteria would be helpful. That is, siRNAs suggested by a combination of tools seem to be more efficient. Furthermore, different factors such as distance of target region to transcription start site, nucleotide composition, absence of off-target effects and secondary structures in the target site and siRNA and the presence of asymmetry and energy valley within the siRNA will increase the efficiency of siRNAs. Despite application of different online tools and fulfilling the criteria, there is no guarantee for designing an effective siRNA. However, meticulous designing of siRNAs according to the suggested algorithms and scoring systems and using different siRNAs for targeting the same gene would lead to improved silencing outcome. In this review, we focus on common algorithms and online software, and introduce a new scoring system used in our experiments.

Mesh:

Substances:

Year:  2016        PMID: 26987292     DOI: 10.1038/cgt.2016.4

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  58 in total

1.  Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells.

Authors:  Patrick J Paddison; Amy A Caudy; Emily Bernstein; Gregory J Hannon; Douglas S Conklin
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

2.  siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference.

Authors:  Yuki Naito; Tomoyuki Yamada; Kumiko Ui-Tei; Shinichi Morishita; Kaoru Saigo
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

3.  Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7.

Authors:  Veit Hornung; Margit Guenthner-Biller; Carole Bourquin; Andrea Ablasser; Martin Schlee; Satoshi Uematsu; Anne Noronha; Muthiah Manoharan; Shizuo Akira; Antonin de Fougerolles; Stefan Endres; Gunther Hartmann
Journal:  Nat Med       Date:  2005-02-20       Impact factor: 53.440

4.  TCF4 silencing sensitizes the colon cancer cell line to oxaliplatin as a common chemotherapeutic drug.

Authors:  Fatemeh Gheidari; Behnaz Bakhshandeh; Ladan Teimoori-Toolabi; Amirhosein Mehrtash; Mahdis Ghadir; Sirous Zeinali
Journal:  Anticancer Drugs       Date:  2014-09       Impact factor: 2.248

5.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.

Authors:  Nan Sook Lee; Taikoh Dohjima; Gerhard Bauer; Haitang Li; Ming-Jie Li; Ali Ehsani; Paul Salvaterra; John Rossi
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

6.  Selecting effective siRNA target sequences for mammalian genes.

Authors:  Shigeru Takasaki; Shuji Kotani; Akihiko Konagaya
Journal:  RNA Biol       Date:  2005-01-05       Impact factor: 4.652

7.  Analysis of gene function in somatic mammalian cells using small interfering RNAs.

Authors:  Sayda M Elbashir; Jens Harborth; Klaus Weber; Thomas Tuschl
Journal:  Methods       Date:  2002-02       Impact factor: 3.608

8.  Site specific enzymatic cleavage of RNA.

Authors:  H Donis-Keller
Journal:  Nucleic Acids Res       Date:  1979-09-11       Impact factor: 16.971

9.  Impact of target mRNA structure on siRNA silencing efficiency: A large-scale study.

Authors:  Joseph A Gredell; Angela K Berger; S Patrick Walton
Journal:  Biotechnol Bioeng       Date:  2008-07-01       Impact factor: 4.530

Review 10.  Interfering with disease: a progress report on siRNA-based therapeutics.

Authors:  Antonin de Fougerolles; Hans-Peter Vornlocher; John Maraganore; Judy Lieberman
Journal:  Nat Rev Drug Discov       Date:  2007-06       Impact factor: 84.694

View more
  31 in total

1.  siRNA Design and GalNAc-Empowered Hepatic Targeted Delivery.

Authors:  Mei Lu; Mengjie Zhang; Bo Hu; Yuanyu Huang
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy.

Authors:  Dinesh Kumar Mishra; Neelam Balekar; Pradyumna Kumar Mishra
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

3.  LinearTurboFold: Linear-Time Global Prediction of Conserved Structures for RNA Homologs with Applications to SARS-CoV-2.

Authors:  Sizhen Li; He Zhang; Liang Zhang; Kaibo Liu; Boxiang Liu; David H Mathews; Liang Huang
Journal:  bioRxiv       Date:  2021-11-15

4.  Co-Delivery of a Short-Hairpin RNA and a shRNA-Resistant Replacement Gene with Adeno-Associated Virus: An Allele-Independent Strategy for Autosomal-Dominant Retinal Disorders.

Authors:  Michael T Massengill; Brianna M Young; Alfred S Lewin; Cristhian J Ildefonso
Journal:  Methods Mol Biol       Date:  2019

5.  RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.

Authors:  Ai-Ming Yu; Young Hee Choi; Mei-Juan Tu
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

6.  Contribution of 3'T and 3'TT overhangs to the thermodynamic stability of model siRNA duplexes.

Authors:  Jolanta Lisowiec-Wachnicka; Brent M Znosko; Anna Pasternak
Journal:  Biophys Chem       Date:  2019-01-07       Impact factor: 2.352

7.  In Vitro Inhibitory Analysis of Rationally Designed siRNAs against MERS-CoV Replication in Huh7 Cells.

Authors:  Sherif Aly El-Kafrawy; Sayed Sartaj Sohrab; Zeenat Mirza; Ahmed M Hassan; Fatima Alsaqaf; Esam Ibraheem Azhar
Journal:  Molecules       Date:  2021-04-29       Impact factor: 4.411

Review 8.  Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles.

Authors:  Jenny G Parvani; Mark W Jackson
Journal:  Endocr Relat Cancer       Date:  2017-02-01       Impact factor: 5.900

9.  The extracellular matrix protein Agrin is expressed by osteoblasts and contributes to their differentiation.

Authors:  Alann Thaffarell Portilho Souza; Helena Bacha Lopes; Fabiola Singaretti Oliveira; Denise Weffort; Gileade Pereira Freitas; Leticia Faustino Adolpho; Roger Rodrigo Fernandes; Adalberto Luiz Rosa; Marcio Mateus Beloti
Journal:  Cell Tissue Res       Date:  2021-07-05       Impact factor: 5.249

10.  Double gene siRNA knockdown of mutant p53 and TNF induces apoptosis in triple-negative breast cancer cells.

Authors:  Valentina Pileczki; Laura Pop; Cornelia Braicu; Livia Budisan; Gabriela Bolba Morar; Paloma Del C Monroig-Bosque; Robert V Sandulescu; Ioana Berindan-Neagoe
Journal:  Onco Targets Ther       Date:  2016-11-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.